DIA
Drug Information Association Logo

LATEST DEVELOPMENTS IN PEDIATRICS

Track:
Special Populations

Day & Time:
March 26, 11:00AM - 12:30PM (Central European Standard Time)

Session Number:
0402

Room Number:
Room H

Type:
Session

Title:
LATEST DEVELOPMENTS IN PEDIATRICS

Chair(s):
Christina Bucci-Rechtweg, DrMed, MD
Head, Pediatric and Maternal Health Policy, Global Drug Regulatory Affairs
Novartis Pharmaceuticals Corporation, United States

Description:
The Paediatric Regulation has set the stage to advance the development of better medicines for children within the broader global regulatory environment. The new PDCO Chair will provide his vision for the future of pediatric drug development in the EU. A representative from the EMA and an Industry representative will provide their perspectives on new developments related to pediatrics, and provide an outlook on opportunities and challenges that lie ahead.

Presentation(s) & Speaker(s):
The PDCO’s Perspective: 2014 and Beyond
Koen Norga
Head of Clinic, Paediatric Oncology
Antwerp University Hospital, Belgium

Opportunities and Challenges: An EMA perspective
Jordi Llinares Garcia, DrMed, MSc
Head of Product Development Scientific Support Department
European Medicines Agency, European Union, United Kingdom

Opportunities and Challenges: An industry perspective
Kate Beaujeux
Senior Regional Regulatory Affairs Director
AstraZeneca, United Kingdom